Principal Financial Group Inc Palatin Technologies Inc Transaction History

Principal Financial Group Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 05, 2020	SELL	$0.41 - $0.73 $11,892 - $21,174	-29,006 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$0.36 - $0.79 $225 - $495	-627 Reduced 2.12%	29,006 $12,000
Q4 2019 Feb 05, 2020	SELL	$0.75 - $0.89 $2,457 - $2,915	-3,276 Reduced 9.95%	29,633 $23,000
Q3 2019 Nov 13, 2019	BUY	$0.78 - $1.09 $6,147 - $8,590	7,881 Added 31.49%	32,909 $30,000
Q2 2019 Aug 12, 2019	SELL	$0.98 - $1.64 $38,668 - $64,711	-39,458 Reduced 61.19%	25,028 $29,000
Q1 2019 May 10, 2019	SELL	$0.67 - $1.01 $3,007 - $4,533	-4,489 Reduced 6.51%	64,486 $63,000
Q4 2018 Feb 14, 2019	SELL	$0.63 - $1.0 $5,265 - $8,358	-8,358 Reduced 10.81%	68,975 $48,000
Q3 2018 Nov 14, 2018	BUY	$0.88 - $1.1 $11,288 - $14,110	12,828 Added 19.89%	77,333 $77,000
Q2 2018 Aug 13, 2018	BUY	$0.91 - $1.45 $58,699 - $93,532	64,505 New	64,505 $0

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $11.2M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.